Gelesis reports mixed data for hydrogel weight loss product

Gelesis Inc. (Boston, Mass.) said lead candidate Gelesis100 met one of two co-primary endpoints in the pivotal GLOW weight loss trial. COO David Pass told BioCentury the company plans to submit the product for regulatory approval and “will move forward based on upcoming discussions with regulatory authorities.”

Gelesis100 is a superabsorbent biodegradable hydrogel that expands in the stomach to create pressure on the stomach walls and increase the feeling of satiety...